Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders

被引:57
|
作者
Jellinger, Kurt A. [1 ]
机构
[1] Inst Clin Neurobiol, A-1070 Vienna, Austria
来源
THESCIENTIFICWORLDJOURNAL | 2011年 / 11卷
关键词
neurodegeneration; alzheimer disease; parkinson disease; protein interaction; coformer seeding; pathogenesis; BETA-AMYLOID PEPTIDES; SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; AMYGDALA LEWY BODIES; TAU-TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; EXTRAPYRAMIDAL SIGNS; ANIMAL-MODELS;
D O I
10.1100/2011/371893
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Protein aggregation is a common characteristic of many neurodegenerative disorders, and the interaction between pathological/toxic proteins to cause neurodegeneration is a hot topic of current neuroscience research. Despite clinical, genetic, and experimental differences, evidence increasingly indicates considerable overlap between synucleinopathies and tauopathies or other protein-misfolding diseases. Inclusions, characteristics of these disorders, also occurring in other neurodegenerative diseases, suggest interactions of pathological proteins engaging common downstream pathways. Novel findings that have shifted our understanding in the role of pathologic proteins in the pathogenesis of Parkinson and Alzheimer diseases have confirmed correlations/overlaps between these and other neurodegenerative disorders. The synergistic effects of alpha-synuclein, hyperphosphorylated tau, amyloid-beta, and other pathologic proteins, and the underlying molecular pathogenic mechanisms, including induction and spread of protein aggregates, are critically reviewed, suggesting a dualism or triad of neurodegeneration in protein-misfolding disorders, although the etiology of most of these processes is still mysterious.
引用
收藏
页码:1893 / 1907
页数:15
相关论文
共 50 条
  • [21] Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders
    Olsen, Cathrine Goberg
    Busk, Oyvind Lovold
    Holla, Oystein Lunde
    Tveten, Kristian
    Holmoy, Trygve
    Tysnes, Ole-Bjorn
    Hoyer, Helle
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2024, 25 (1-2) : 177 - 187
  • [22] Alpha-synuclein: a chaperone involved in neurodegenerative disorders
    Birman, S
    M S-MEDECINE SCIENCES, 2000, 16 (8-9): : 956 - 957
  • [23] Are β-synuclein derivatives an alternative approach for treatment of neurodegenerative disorders
    Windisch, M
    Hutter-Paier, B
    Masliah, E
    Rockenstein, E
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S409 - S409
  • [24] Alpha-synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders
    Kawada, Tomoyuki
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2021, 35 (02): : 187 - 187
  • [25] Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders
    Szenasi, Tibor
    Turu, Gabor
    Hunyady, Laszlo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [26] Role of FET proteins in neurodegenerative disorders
    Svetoni, Francesca
    Frisone, Paola
    Paronetto, Maria Paola
    RNA BIOLOGY, 2016, 13 (11) : 1089 - 1102
  • [27] Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
    Windisch, Manfred
    Wolf, Hans-Joerg
    Hutter-Paier, Birgit
    Wronski, Robert
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (05) : 556 - 561
  • [28] The potential role of CGRP in synuclein-associated neurodegenerative disorders
    Alexoudi, Athanasia
    Donadio, Vincenzo
    Karageorgiou, Elissaios
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [29] Neuroprotective β-synuclein derivatives?: An alternative approach for the treatment of neurodegenerative disorders
    Windisch, M
    NEUROBIOLOGY OF AGING, 2004, 25 : S29 - S29
  • [30] Heat shock proteins and neurodegenerative disorders
    Soo, Eliza Ting-Li
    Ng, Yee-Kong
    Bay, Boon-Huat
    Yip, George Wai-Cheong
    THESCIENTIFICWORLDJOURNAL, 2008, 8 : 270 - 274